You are here: Fairness.com > Resources > How Bright Promise in Cancer Testin...

How Bright Promise in Cancer Testing Fell Apart

Date: July 7, 2011

Author: Gina Kolata

QUOTE: as patients and their doctors try to make critical decisions about serious illnesses, they may be getting worthless information that is based on bad science. The scientific world is concerned enough that two prominent groups, the National Cancer Institute and the Institute of Medicine, have begun examining the Duke case; they hope to find new ways to evaluate claims based on emerging and complex analyses of patterns of genes and other molecules.

• Read it: New York Times
• Tell a friend
• Add a Comment*

Article MetaInformation:

Key People:

Key Organizations:

• Food and Drug Administration (FDA)
• Institute of Medicine (IOM)
• National Cancer Institute (NCI)
• New York Times Company

Subject & Geographic Categories:

• Abstract Principles
  • Information
    • Truth / Honesty / Lying / Cheating
      • Hide/Mislead
        • Disclosure/Conflicts of Interest
          • Disclosure/Conflict of Interest (Individual)
  • Motivation/Rewards/Punishments
  • Timing / Delay / Procrastination

• Government & Politics / History
  • Government (General)
    • Government Regulation
      • Business Regulation

• Health & Medicine
  • Drugs: Prescription/Non-Prescription
  • Health Care Business
    • Pharmaceutical / Drug / Biotech

• Science & Technology
  • Research Ethics
  • Technological Risk/Innovation/Utilization

• North America
  • United States of America/USA

• Worldwide

Comments:

none

• Add a Comment*

*User comments are posted without Fairness.com LLC's prior review or approval, and Fairness.com LLC takes no responsibility for them; please see our Conditions of Service Agreement.

Please send your comments and suggestions to the Webmaster. © copyright 1999-2009, Fairness.com LLC.
"Fairness.com" and "Life isn't fair... but we're working on it" are service marks of Fairness.com LLC. All rights reserved.